B

BOLT

Bolt Biotherapeutics, Inc.

5.19

0.35+7.23%
After Hours: 5.03  -0.16  -3.08%16:10 09/05 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

99.63M

159.78M

227.81M

307.72M

46.54M

Total Current Assets

50.81M

105.71M

172.75M

189.16M

25.36M

Total Non Current Assets

48.82M

54.08M

55.06M

118.56M

21.18M

Total Liabilities

42.43M

47.04M

56.30M

57.60M

46.19M

Total Current Liabilities

15.86M

20.46M

23.12M

21.33M

11.26M

Total Non Current Liabilities

26.58M

26.59M

33.18M

36.27M

34.93M

Total Equity

57.20M

112.74M

171.51M

250.12M

349.00K

Total Stockholders Equity

57.20M

112.74M

171.51M

250.12M

349.00K

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

99.63M

159.78M

227.81M

307.72M

46.54M

Total Common Shares Outstanding

1.92M

1.91M

1.89M

1.87M

1.82M

Total Preferred Shares Outstanding

--

--

--

--

--